Workforce Considerations When Building a Precision Medicine Program

This paper describes one healthcare system’s approach to strategically deploying genetic specialists and pharmacists to support the implementation of a precision medicine program. In 2013, Sanford Health initiated the development of a healthcare system-wide precision medicine program. Here, we report the necessary staffing including the genetic counselors, genetic counseling assistants, pharmacists, and geneticists. We examined the administrative and electronic medical records data to summarize genetic referrals over time as well as the uptake and results of an enterprise-wide genetic screening test. Between 2013 and 2020, the number of genetic specialists employed at Sanford Health increased by 190%, from 10.1 full-time equivalents (FTEs) to 29.3 FTEs. Over the same period, referrals from multiple provider types to genetic services increased by 423%, from 1438 referrals to 7517 referrals. Between 2018 and 2020, 11,771 patients received a genetic screening, with 4% identified with potential monogenic medically actionable predisposition (MAP) findings and 95% identified with at least one informative pharmacogenetic result. Of the MAP-positive patients, 85% had completed a session with a genetics provider. A strategic workforce staffing and deployment allowed Sanford Health to manage a new genetic screening program, which prompted a large increase in genetic referrals. This approach can be used as a template for other healthcare systems interested in the development of a precision medicine program.

[1]  Irma N. Ramos,et al.  Limited Genomics Training Among Physicians Remains a Barrier to Genomics-Based Implementation of Precision Medicine , 2022, Frontiers in Medicine.

[2]  M. Murray,et al.  Improved provider preparedness through an 8-part genetics and genomic education program. , 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

[3]  Matthew S. Lebo,et al.  Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization , 2021, medRxiv.

[4]  R. Green,et al.  Primary care providers’ responses to unsolicited Lynch syndrome secondary findings of varying clinical significance , 2021, Genetics in Medicine.

[5]  M. Watson,et al.  The 2019 US medical genetics workforce: a focus on clinical genetics , 2021, Genetics in Medicine.

[6]  R. Green,et al.  Precision Population Medicine in Primary Care: The Sanford Chip Experience , 2021, Frontiers in Genetics.

[7]  M. Raspa,et al.  Barriers and Facilitators to Genetic Service Delivery Models: Scoping Review , 2021, Interactive journal of medical research.

[8]  N. Petry,et al.  The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice , 2021, Annals of translational medicine.

[9]  A. Kenneson,et al.  Genetic Referral Patterns and Responses to Clinical Scenarios: A Survey of Primary Care Providers and Clinical Geneticists , 2021, Journal of primary care & community health.

[10]  G. Barsh,et al.  A state-based approach to genomics for rare disease and population screening , 2020, Genetics in Medicine.

[11]  P. Hulick,et al.  Primary Care Physician Experiences with Integrated Population-Scale Genetic Testing: A Mixed-Methods Assessment , 2020, Journal of personalized medicine.

[12]  A. Slonim,et al.  Population genetic screening efficiently identifies carriers of autosomal dominant diseases , 2020, Nature Medicine.

[13]  K. Musunuru,et al.  Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. , 2020, Circulation. Genomic and precision medicine.

[14]  Laney K. Jones,et al.  Clinical outcomes of a genomic screening program for actionable genetic conditions , 2020, Genetics in Medicine.

[15]  L. Lynd,et al.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review , 2020, Genetics in Medicine.

[16]  Marc S. Williams,et al.  Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic , 2020, Genetics in Medicine.

[17]  A. Mitchell,et al.  The current state of genetic counseling assistants in the United States , 2019, Journal of genetic counseling.

[18]  B. Yashar,et al.  Primary care physicians’ understanding and utilization of pediatric exome sequencing results , 2019, Journal of genetic counseling.

[19]  Russell A Wilke,et al.  Implementation of wide-scale pharmacogenetic testing in primary care. , 2019, Pharmacogenomics.

[20]  Judy C. Boughey,et al.  Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons , 2019, Annals of Surgical Oncology.

[21]  David C. Kochan,et al.  The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results , 2018, Mayo Clinic proceedings.

[22]  Kathryn A Phillips,et al.  Genetic Test Availability And Spending: Where Are We Now? Where Are We Going? , 2018, Health affairs.

[23]  Laurie L. Novak,et al.  Physicians' Perspectives on Receiving Unsolicited Genomic Results , 2018, Genetics in Medicine.

[24]  Jeffrey W. Pennington,et al.  Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings , 2018, Genetics in Medicine.

[25]  R. Bennett,et al.  Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study , 2018, Journal of Genetic Counseling.

[26]  R. Green,et al.  Communication challenges for nongeneticist physicians relaying clinical genomic results. , 2017, Personalized medicine.

[27]  Matthew S. Lebo,et al.  The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. , 2017, Annals of internal medicine.

[28]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[29]  H. Hoyme,et al.  Patient and Physician Perceptions of Genetic Testing in Primary Care. , 2016, South Dakota medicine : the journal of the South Dakota State Medical Association.

[30]  Baukje Miedema,et al.  Primary care providers' experiences with and perceptions of personalized genomic medicine. , 2016, Canadian family physician Medecin de famille canadien.

[31]  Denise L. Perry,et al.  Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.

[32]  D. Ledbetter,et al.  The Geisinger MyCode Community Health Initiative: an electronic health record-linked biobank for Precision Medicine research , 2015, Genetics in Medicine.

[33]  Euan A Ashley,et al.  The precision medicine initiative: a new national effort. , 2015, JAMA.

[34]  U. P. S. T. Force.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement. , 2015, American family physician.

[35]  R. Green,et al.  'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. , 2015, Personalized medicine.

[36]  Karen Marder,et al.  Attitudes and Practices Among Internists Concerning Genetic Testing , 2013, Journal of Genetic Counseling.

[37]  W. Burke,et al.  Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? , 2013, Genetics in Medicine.

[38]  M. Robson,et al.  American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. , 2010, Journal of Clinical Oncology.

[39]  J. Leppäluoto.  Biobank research , 2006, International Journal of Circumpolar Health.

[40]  R. Green,et al.  Reconciling Opportunistic and Population Screening in Clinical Genomics , 2019, Mayo Clinic proceedings.

[41]  ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer. , 2018, Obstetrics and gynecology.

[42]  M. Dwyer,et al.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[43]  Kate C. Arnold,et al.  Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders , 2016, Obstetrics and gynecology.

[44]  Dierdre B. Axell-House,et al.  Primary Care Physicians Experience and Confidence with Genetic Testing and Perceived Barriers to Genomic Medicine , 2015 .

[45]  Heather L. Maracle,et al.  Primary Care Providers , 2012 .